Bryce Point Capital’s CONMED CNMD Stock Holding History

Bryce Point Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,912	Closed	-$473K	–	236
2024 Q4	$473K	Buy	+6,912	New	+$482K	0.14%	341

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Bryce Point Capital's CNMD Position: Q1 2025 in Review

Bryce Point Capital sold out of CONMED (CNMD) in Q1 2025, closing a stake of 6,912 shares — an estimated $473K sold.

Bryce Point Capital first reported a position in CNMD in Q4 2024 and held it in 1 quarter. The position peaked at $473K in Q4 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

Bryce Point Capital reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 6,912 CONMED shares in Q1 2025, an estimated $473K.
Bryce Point Capital first reported a position in CONMED in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's CONMED position peaked at $473K in Q4 2024.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.